Federal Bureau of Prisons
Audit of DOJ's Efforts to Protect BOP Facilities Against Threats Posed by Unmanned Aircraft Systems
The OIG is auditing the Department's efforts to protect BOP facilities against threats posed by unmanned aircraft systems, commonly referred to as drones. The preliminary objectives are to: (1) determine the extent to which the BOP can detect and track attempts to deliver contraband to BOP facilities via drones, and (2) assess the Department's current policies and efforts to protect BOP facilities against security threats posed by drones.
Audit of the Federal Bureau of Prison's Contracts Awarded to the University of Massachusetts Medical School
The OIG is conducting an audit of the BOP's comprehensive medical services contracts awarded to the University of Massachusetts Medical School (UMass). The preliminary objective of the audit is to assess BOP’s administration of the contracts, and UMass’ performance and compliance with the terms, conditions, laws, and regulations applicable to these contracts. The assessment of performance may include financial management, monitoring, reporting, and progress toward meeting the contract goals and objectives.
Audits of the U.S. Department of Justice and Select Components Annual Financial Statements Fiscal Year 2019
The OIG is auditing DOJ and select components Annual Financial Statements for fiscal year 2019. Pursuant to Section 304(a) of the Chief Financial Officers Act of 1990, as expanded by Section 405(b) of the Government Management Reform Act of 1994, the OIG is required to perform an audit of the Department’s annual financial statements. Additionally, the Civil Asset Forfeiture Reform Act of 2000 requires an audit of the Assets Forfeiture Fund/Seized Asset Deposit Fund annual financial statements, and the Government Corporation Control Act of 1945, as amended, requires an audit of the Federal Prison Industries, Inc. annual financial statements. The OIG has contracted with the independent public accounting firm, KPMG LLP, to perform the audits.
BOP Counterterrorism Efforts
The OIG is conducting an audit of the BOP's counterterrorism efforts. The preliminary objectives are to review the BOP’s policies, procedures, and practices for monitoring communications of inmates with known or suspected ties to domestic and foreign terrorism and its efforts to prevent further radicalization among its inmate population.
BOP Non-Lethal/Lethal Fence System Updates and Improvements Contract Awarded to DeTekion Security Systems, Inc.
The OIG is conducting an audit of the BOP's contract awarded to DeTekion Security Systems, Inc., and the related initial contract actions to install non-lethal/lethal fence systems at nine United States Penitentiaries (USP). A non-lethal/lethal electrified fence has the capacity to administer a non-lethal shock to initially stun someone touching the fence and then switch to deliver a lethal shock if that person touches the fence a second time. The objectives are to: (1) evaluate BOP and contractor efforts on the design of the non-lethal/lethal fences installed at the nine USPs during the initial and current contract actions, (2) evaluate BOP’s price analysis of the fence upgrade contract, (3) assess BOP’s oversight of the fence upgrade contract, and (4) to evaluate BOP perimeter security strategy incorporated at the nine USPs that have DeTekion lethal/non-lethal fences.
BOP's Efforts to Address Inmate Sexual Harassment and Sexual Assault Against BOP Staff
The OIG is conducting a review of the BOP's efforts to address inmate-on-staff sexual misconduct. The review will assess the prevalence and impacts of inmate-on-staff sexual misconduct, including sexual harassment, assault, and abuse, in BOP institutions from fiscal year (FY) 2008 through FY 2018.
DOJ's Compliance with the Federal Funding Accountability and Transparency Act of 2006, as amended by the DATA Act of 2014
The OIG is examining DOJ's compliance with reporting requirements under the Federal Funding Accountability and Transparency Act, as amended by the DATA Act. Through memorandum M-15-12, Increasing Transparency of Federal Spending by Making Federal Spending Data Accessible, Searchable, and Reliable, the Office of Management and Budget provided guidance to federal agencies on the requirements that agencies must employ pursuant to the DATA Act. The OIG will review a statistically valid sampling of the fiscal year 2019 spending data submitted, and submit to Congress and make publicly available a report assessing the completeness, timeliness, quality, and accuracy of the data sampled.
Examination of the Federal Bureau of Prisons Compliance with the Government Charge Card Abuse Prevention Act of 2012 and OMB Circular A-123, Appendix B
The OIG had initiated an examination of the Federal Bureau of Prison’s compliance with the Government Charge Card Abuse Prevention Act of 2012 and OMB Circular A-123, Appendix B, Improving the Management of Government Charge Card Programs, for the 9 months ending December 31, 2019.
Review of the Department of Justice’s Preparedness to Respond to Critical Incidents Under Emergency Support Function 13
The OIG is reviewing the Department’s ability to meet its responsibilities under Emergency Support Function 13 (ESF-13) and to execute ESF-13 activities in response to natural and manmade disasters. OIG will assess Departmental policies and guidance; planning, preparation, training, and execution processes; and coordination among DOJ law enforcement components and non-DOJ support agencies in support of an ESF-13 activation.
Review of the Federal Bureau of Prisons' Policy Development Process
The OIG is conducting a review of the BOP’s policy development process, including how existing processes and oversight impact policy development. The OIG will examine the factors that may impede the BOP from revising national policies in a timely manner and assess BOP performance metrics to evaluate the success of its policy development process.
Review of the Federal Bureau of Prisons' Pharmaceutical Drug Costs for Inmates
The OIG is conducting a review of the BOP’s pharmaceutical drug costs for inmates. This review will examine the BOP’s drug rates and spending, its drug procurement process, and its effort to control rising drug costs. Included in this review is a more specific evaluation of the BOP’s management of Hepatitis C.
To detect and deter waste, fraud, abuse, and misconduct in DOJ programs and personnel, and to promote economy and efficiency in those programs.